AIP
DAWN

Ameritas Investment Partners’s Day One Biopharmaceuticals DAWN Stock Holding History

Ameritas Investment Partners’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$138K Buy
6,422
+409
+7% +$5.76K ﹤0.01% 1497
2025
Q4 		$56K Hold
6,013
– – ﹤0.01% 2046
2025
Q3 		$42.4K Sell
6,013
-1,336
-18% -$9.19K ﹤0.01% 2260
2025
Q2 		$47.8K Buy
7,349
+2,264
+45% +$15.6K ﹤0.01% 2210
2025
Q1 		$40.3K Hold
5,085
– – ﹤0.01% 2233
2024
Q4 		$64.4K Hold
5,085
– – ﹤0.01% 2036
2024
Q3 		$70.8K Hold
5,085
– – ﹤0.01% 1989
2024
Q2 		$70.1K Sell
5,085
-1,194
-19% -$17.5K ﹤0.01% 1952
2024
Q1 		$104K Hold
6,279
– – ﹤0.01% 1715
2023
Q4 		$91.7K Hold
6,279
– – ﹤0.01% 1794
2023
Q3 		$77K Buy
6,279
+2,213
+54% +$28.9K ﹤0.01% 1832
2023
Q2 		$48.5K Buy
4,066
+1,895
+87% +$24.8K ﹤0.01% 2070
2023
Q1 		$29K Hold
2,171
– – ﹤0.01% 2293
2022
Q4 		$47.3K Hold
2,171
– – ﹤0.01% 2091
2022
Q3 		$43K Buy
2,171
+407
+23% +$8.66K ﹤0.01% 2089
2022
Q2 		$31K Hold
1,764
– – ﹤0.01% 2290
2022
Q1 		$17K Buy
1,764
+919
+109% +$12.1K ﹤0.01% 2617
2021
Q4 		$14K Hold
845
– – ﹤0.01% 2779
2021
Q3 		$20K Buy
+845
New +$20.3K ﹤0.01% 2691

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Ameritas Investment Partners's DAWN Position: Q1 2026 in Review

Ameritas Investment Partners increased its Day One Biopharmaceuticals (DAWN) stake by 6.8% in Q1 2026, buying an estimated $5.76K and bringing the position to 6,422 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #1497.

Ameritas Investment Partners first reported a position in DAWN in Q3 2021 and has held it in 19 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Ameritas Investment Partners held 6,422 shares of Day One Biopharmaceuticals worth $138K as of Q1 2026.
  • Ameritas Investment Partners bought 409 Day One Biopharmaceuticals shares in Q1 2026, an estimated $5.76K.
  • Day One Biopharmaceuticals made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #1497 holding.
  • Ameritas Investment Partners first reported a position in Day One Biopharmaceuticals in Q3 2021 and has held it in 19 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.